Abstract OT-24-01: Phase I study combining ipatasertib with chemotherapy and atezolizumab in patients with metastatic triple negative breast cancer

2021 ◽  
Author(s):  
Yuan Yuan ◽  
Susan E. Yost ◽  
Jin Sun Lee ◽  
Paul H. Frankel ◽  
Christopher Ruel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Triple Negative Breast Cancer ◽  
Phase I Study ◽  
Triple Negative

scholarly journals Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation–Associated Breast Cancer

2016 ◽  
Vol 22 (12) ◽  
pp. 2855-2864 ◽  
Author(s):  
Eve T. Rodler ◽  
Brenda F. Kurland ◽  
Melissa Griffin ◽  
Julie R. Gralow ◽  
Peggy Porter ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Triple Negative Breast Cancer ◽  
Phase I Study ◽  
Triple Negative ◽  
Brca Mutation

A phase I study of JS001, a humanized PD-1mAbin patients with advanced triple negative breast cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e15093-e15093 ◽  
Author(s):  
Li Bian ◽  
Huiqiang Zhang ◽  
Tao Wang ◽  
Shaohua Zhang ◽  
Jianbin Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Triple Negative Breast Cancer ◽  
Phase I Study ◽  
Triple Negative

scholarly journals Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer

Oncotarget ◽  
2016 ◽  
Vol 8 (2) ◽  
pp. 2320-2328 ◽  
Author(s):  
Marzia A. Locatelli ◽  
Philippe Aftimos ◽  
E. Claire Dees ◽  
Patricia M. LoRusso ◽  
Mark D. Pegram ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Triple Negative Breast Cancer ◽  
Phase I Study ◽  
Triple Negative ◽  
Gamma Secretase ◽  
Secretase Inhibitor ◽  
Gamma Secretase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document